Literature DB >> 25680271

The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation.

Michel DuPage1, Gaurav Chopra1, Jason Quiros1, Wendy L Rosenthal1, Malika M Morar1, Dan Holohan1, Ruan Zhang2, Laurence Turka2, Alexander Marson3, Jeffrey A Bluestone4.   

Abstract

Regulatory T cells (Treg cells) are required for immune homeostasis. Chromatin remodeling is essential for establishing diverse cellular identities, but how the epigenetic program in Treg cells is maintained throughout the dynamic activation process remains unclear. Here we have shown that CD28 co-stimulation, an extracellular cue intrinsically required for Treg cell maintenance, induced the chromatin-modifying enzyme, Ezh2. Treg-specific ablation of Ezh2 resulted in spontaneous autoimmunity with reduced Foxp3(+) cells in non-lymphoid tissues and impaired resolution of experimental autoimmune encephalomyelitis. Utilizing a model designed to selectively deplete wild-type Treg cells in adult mice co-populated with Ezh2-deficient Treg cells, Ezh2-deficient cells were destabilized and failed to prevent autoimmunity. After activation, the transcriptome of Ezh2-deficient Treg cells was disrupted, with altered expression of Treg cell lineage genes in a pattern similar to Foxp3-deficient Treg cells. These studies reveal a critical role for Ezh2 in the maintenance of Treg cell identity during cellular activation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25680271      PMCID: PMC4347854          DOI: 10.1016/j.immuni.2015.01.007

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  48 in total

1.  Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets.

Authors:  J L Grogan; M Mohrs; B Harmon; D A Lacy; J W Sedat; R M Locksley
Journal:  Immunity       Date:  2001-03       Impact factor: 31.745

2.  Distinct BMI-1 and EZH2 expression patterns in thymocytes and mature T cells suggest a role for Polycomb genes in human T cell differentiation.

Authors:  F M Raaphorst; A P Otte; F J van Kemenade; T Blokzijl; E Fieret; K M Hamer; D P Satijn; C J Meijer
Journal:  J Immunol       Date:  2001-05-15       Impact factor: 5.422

3.  Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells.

Authors:  Qizhi Tang; Kammi J Henriksen; Elisa K Boden; Aaron J Tooley; Jianqin Ye; Sumit K Subudhi; Xin X Zheng; Terry B Strom; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

4.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

Authors:  B Salomon; D J Lenschow; L Rhee; N Ashourian; B Singh; A Sharpe; J A Bluestone
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

5.  CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes.

Authors:  D J Lenschow; K C Herold; L Rhee; B Patel; A Koons; H Y Qin; E Fuchs; B Singh; C B Thompson; J A Bluestone
Journal:  Immunity       Date:  1996-09       Impact factor: 31.745

Review 6.  An epigenetic view of helper T cell differentiation.

Authors:  K Mark Ansel; Dong U Lee; Anjana Rao
Journal:  Nat Immunol       Date:  2003-07       Impact factor: 25.606

7.  Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement.

Authors:  I-Hsin Su; Ashwin Basavaraj; Andrew N Krutchinsky; Oliver Hobert; Axel Ullrich; Brian T Chait; Alexander Tarakhovsky
Journal:  Nat Immunol       Date:  2002-12-23       Impact factor: 25.606

8.  Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state.

Authors:  Sylvain Fisson; Guillaume Darrasse-Jèze; Elena Litvinova; Franck Septier; David Klatzmann; Roland Liblau; Benoît L Salomon
Journal:  J Exp Med       Date:  2003-08-25       Impact factor: 14.307

9.  Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.

Authors:  Estelle Bettelli; Maria Pagany; Howard L Weiner; Christopher Linington; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

10.  Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells.

Authors:  Aaron Arvey; Joris van der Veeken; Robert M Samstein; Yongqiang Feng; John A Stamatoyannopoulos; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2014-04-13       Impact factor: 25.606

View more
  115 in total

Review 1.  Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.

Authors:  Michel DuPage; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2016-02-15       Impact factor: 53.106

2.  Single-Cell Chromatin Modification Profiling Reveals Increased Epigenetic Variations with Aging.

Authors:  Peggie Cheung; Francesco Vallania; Hayley C Warsinske; Michele Donato; Steven Schaffert; Sarah E Chang; Mai Dvorak; Cornelia L Dekker; Mark M Davis; Paul J Utz; Purvesh Khatri; Alex J Kuo
Journal:  Cell       Date:  2018-04-26       Impact factor: 41.582

3.  DNA methylation secures CD4(+) and CD8(+) T cell lineage borders.

Authors:  Yongqiang Feng; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2015-07       Impact factor: 25.606

Review 4.  Regulation of T cell differentiation and function by epigenetic modification enzymes.

Authors:  Huicheng Liu; Pingfei Li; Zhengping Wei; Cai Zhang; Minghui Xia; Qiuyang Du; Yufei Chen; Na Liu; Huabin Li; Xiang-Ping Yang
Journal:  Semin Immunopathol       Date:  2019-04-08       Impact factor: 9.623

Review 5.  Emerging Role for Methylation in Multiple Sclerosis: Beyond DNA.

Authors:  Lindsay M Webb; Mireia Guerau-de-Arellano
Journal:  Trends Mol Med       Date:  2017-05-04       Impact factor: 11.951

Review 6.  Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation.

Authors:  Cameron McDonald-Hyman; Laurence A Turka; Bruce R Blazar
Journal:  Sci Transl Med       Date:  2015-03-25       Impact factor: 17.956

7.  Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy.

Authors:  Sangeeta Goswami; Irina Apostolou; Jan Zhang; Jill Skepner; Swetha Anandhan; Xuejun Zhang; Liangwen Xiong; Patrick Trojer; Ana Aparicio; Sumit K Subudhi; James P Allison; Hao Zhao; Padmanee Sharma
Journal:  J Clin Invest       Date:  2018-07-30       Impact factor: 14.808

Review 8.  Epigenetic mechanisms of tumor resistance to immunotherapy.

Authors:  Natalia Arenas-Ramirez; Dilara Sahin; Onur Boyman
Journal:  Cell Mol Life Sci       Date:  2018-08-23       Impact factor: 9.261

Review 9.  Immunometabolism of regulatory T cells.

Authors:  Ryan Newton; Bhavana Priyadharshini; Laurence A Turka
Journal:  Nat Immunol       Date:  2016-05-19       Impact factor: 25.606

Review 10.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.